lobbying_activities: 3089469

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts. Sortable columns (indexed): client_name, issue_code, filing_year, filing_uuid. Sorting on any other column returns HTTP 400 (2026-09-04, #697) — use ?sql= with your own ORDER BY if you need it.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	is_no_activity	is_termination	received_date
3089469	f4c309ed-94a3-4d80-b080-9e31e4b35d12	Q4	RED+BLUE STRATEGIES	400693064	CAMBIA HEALTH SOLUTIONS (FORMERLY KNOWN AS THE REGENCE GROUP)	2023	fourth_quarter	MMM	HR 6363 - Further Continuing Appropriations and other Extenders Act - Support for critical government programs remaining operational and available. HR 5860 - Continuing Appropriations Act of FY 2024 and other Extensions Act - Support for critical government programs remaining operational and available. S. 3430 Better Mental Health Care, Lower Cost Prescription Drugs and Extenders Act of 2023- Issues related to supporting health plans that are working to ensure that there are tools available to provide access to mental health care for families as well as ensuring that tools used to keep prices of prescription medication affordable. H.R. 3561 - The PATIENT Act of 2023 - Issues related to Plans and PBMs and their ability to successfully support the national goal of bringing down the cost of prescription medications in the Medicare program. H.R. 5378 - Lower Costs, More Transparency Act of 2023 - Issues related to plans and PBMs and their ability to successfully support the national goal of bringing down the cost of prescription medications in the Medicare program. S. 2973 - Modernizing and Ensuring PBM Accountability Act of 2023 - Issues related to Plans and PBMs and their ability to successfully support the national goal of bringing down the cost of prescription medications in the Medicare program. Issues related to the successful implementation of the Inflation Reduction Act with a focus on lowering prescription medication prices in the Medicare program and ensuring affordable coverage options in the Marketplaces. HHS and CMS Rules and Regulations focused on the Medicare Advantage program including: CY 2024 Rate Announcement, CY 2024 Medicare Advantage technical rules. Issues related improving outcomes and access in mental and behavioral health in Medicare, Medicaid and the Marketplaces. Issues related to developing coherent prior authorization methodologies. Issues related to the Public Health Emergency and the impact that unwinding will have on individuals access to quality, affordable health care coverage in Medicaid and the Marketplaces.	HOUSE OF REPRESENTATIVES,SENATE	0	0	2023-12-31T13:19:04-05:00